Cargando…
Application of small molecule FPR1 antagonists in the treatment of cancers
The formylpeptide receptor-1 (FPR1) is a member of the chemotactic GPCR-7TM formyl peptide receptor family, whose principle function is in trafficking of various leukocytes into sites of bacterial infection and inflammation. More recently, FPR1 has been shown to be expressed in different types of ca...
Autores principales: | Ahmet, Djevdet S., Basheer, Haneen A., Salem, Anwar, Lu, Di, Aghamohammadi, Amin, Weyerhäuser, Patrick, Bordiga, Andrea, Almeniawi, Juman, Rashid, Sabah, Cooper, Patricia A., Shnyder, Steven D., Vinader, Victoria, Afarinkia, Kamyar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560711/ https://www.ncbi.nlm.nih.gov/pubmed/33057069 http://dx.doi.org/10.1038/s41598-020-74350-z |
Ejemplares similares
-
Discovery and Computer Aided Potency Optimization of a Novel Class of Small Molecule CXCR4 Antagonists
por: Vinader, Victoria, et al.
Publicado: (2013) -
Agarose Spot as a Comparative Method for in situ Analysis of Simultaneous Chemotactic Responses to Multiple Chemokines
por: Ahmed, Mohaned, et al.
Publicado: (2017) -
Study of the Chemotactic Response of Multicellular Spheroids in a Microfluidic Device
por: Ayuso, Jose M., et al.
Publicado: (2015) -
Synthesis of a Pseudo-Disaccharide Library and Its Application to the Characterisation of the Heparanase Catalytic Site
por: Vinader, Victoria, et al.
Publicado: (2013) -
Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment
por: Basheer, Haneen A., et al.
Publicado: (2023)